Both BPC-157 and TB-500 have extensive independent published research bases, with additional evidence emerging from combination studies that specifically document the synergistic interactions between the two compounds
Safety: Its important to note that while AOD-9604 demonstrated excellent safety and tolerability, the clinical development program was ultimately discontinued because efficacy for weight loss did not meet regulatory approval standards
A key safety advantage of AOD-9604: it does not bind or activate the growth hormone receptor [1]
Beyond this core list, several other conditions are commonly tied to B12 deficiency: autoimmune gastritis (which damages the parietal cells that produce intrinsic factor), ileal resection (surgical removal of the part of the small intestine where B12 is absorbed), chronic alcoholism , pancreatic insufficiency , nitrous oxide exposure (including recreational use, which inactivates B12), and increased demand during pregnancy and breastfeeding
These products are intended exclusively for laboratory research purposes and are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition